Literature DB >> 23929067

Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodeling.

Aida Moreno-Moral1, Massimiliano Mancini, Giulia D'Amati, Paolo Camici, Enrico Petretto.   

Abstract

Hypertension and cardiomyopathies share maladaptive changes of cardiac morphology, eventually leading to heart failure. These include left ventricular hypertrophy (LVH), myocardial fibrosis, and structural remodeling of coronary microcirculation, which is the morphologic hallmark of coronary microvascular dysfunction. To pinpoint the complex molecular mechanisms and pathways underlying LVH-associated cardiac remodeling independent of blood pressure effects, we employed gene network approaches to the rat heart. We used the Spontaneously Hypertensive Rat model showing many features of human hypertensive cardiomyopathy, for which we collected histological and histomorphometric data of the heart and coronary vasculature, and genome-wide cardiac gene expression. Here, we provide a large catalogue of gene co-expression networks in the heart that are significantly associated with quantitative variation in LVH, microvascular remodeling, and fibrosis-related traits. Many of these networks were significantly conserved to human idiopathic and/or ischemic cardiomyopathy patients, suggesting a potential role for these co-expressed genes in human heart disease.

Entities:  

Mesh:

Year:  2013        PMID: 23929067     DOI: 10.1007/s12265-013-9504-x

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  47 in total

1.  Heritability of left ventricular mass in a large cohort of twins.

Authors:  Pankaj Sharma; Rita P S Middelberg; Toby Andrew; Michael R Johnson; Howard Christley; Morris J Brown
Journal:  J Hypertens       Date:  2006-02       Impact factor: 4.844

Review 2.  Molecular networks as sensors and drivers of common human diseases.

Authors:  Eric E Schadt
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

Review 3.  The coronary circulation and blood flow in left ventricular hypertrophy.

Authors:  Paolo G Camici; Iacopo Olivotto; Ornella E Rimoldi
Journal:  J Mol Cell Cardiol       Date:  2011-09-05       Impact factor: 5.000

4.  Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms.

Authors:  I E Blom; A J van Dijk; R A de Weger; M G Tilanus; R Goldschmeding
Journal:  Mol Pathol       Date:  2001-06

5.  Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.

Authors:  Dimitris Tousoulis; Emmanuel Androulakis; Nikolaos Papageorgiou; Antigoni Miliou; Evaggelos Chatzistamatiou; Evaggelos Oikonomou; George Moustakas; Ioannis Kallikazaros; Christodoulos Stefanadis
Journal:  Am J Hypertens       Date:  2013-03-11       Impact factor: 2.689

Review 6.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

7.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

8.  Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease.

Authors:  Norbert Hubner; Caroline A Wallace; Heike Zimdahl; Enrico Petretto; Herbert Schulz; Fiona Maciver; Michael Mueller; Oliver Hummel; Jan Monti; Vaclav Zidek; Alena Musilova; Vladimir Kren; Helen Causton; Laurence Game; Gabriele Born; Sabine Schmidt; Anita Müller; Stuart A Cook; Theodore W Kurtz; John Whittaker; Michal Pravenec; Timothy J Aitman
Journal:  Nat Genet       Date:  2005-02-13       Impact factor: 38.330

9.  Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study.

Authors:  A I Lynch; W Tang; G Shi; R B Devereux; J H Eckfeldt; D K Arnett
Journal:  J Hum Hypertens       Date:  2011-01-20       Impact factor: 3.012

10.  High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease.

Authors:  Sushma Rekhraj; Stephen J Gandy; Benjamin R Szwejkowski; M Adnan Nadir; Awsan Noman; J Graeme Houston; Chim C Lang; Jacob George; Allan D Struthers
Journal:  J Am Coll Cardiol       Date:  2013-03-05       Impact factor: 24.094

View more
  7 in total

Review 1.  Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013.

Authors:  Emanuele Barbato; Enrique Lara-Pezzi; Craig Stolen; Angela Taylor; Paul J Barton; Jozef Bartunek; Paul Iaizzo; Daniel P Judge; Lorrie Kirshenbaum; Burns C Blaxall; Andre Terzic; Jennifer L Hall
Journal:  J Cardiovasc Transl Res       Date:  2014-07       Impact factor: 4.132

2.  Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice.

Authors:  Christoph D Rau; Milagros C Romay; Mary Tuteryan; Jessica J-C Wang; Marc Santolini; Shuxun Ren; Alain Karma; James N Weiss; Yibin Wang; Aldons J Lusis
Journal:  Cell Syst       Date:  2016-11-17       Impact factor: 10.304

Review 3.  Linking Genes to Cardiovascular Diseases: Gene Action and Gene-Environment Interactions.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2015-11-06       Impact factor: 4.132

Review 4.  Genomic approaches for the elucidation of genes and gene networks underlying cardiovascular traits.

Authors:  M E Adriaens; C R Bezzina
Journal:  Biophys Rev       Date:  2018-06-22

5.  WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling.

Authors:  Huimei Chen; Aida Moreno-Moral; Francesco Pesce; Nithya Devapragash; Massimiliano Mancini; Ee Ling Heng; Maxime Rotival; Prashant K Srivastava; Nathan Harmston; Kirill Shkura; Owen J L Rackham; Wei-Ping Yu; Xi-Ming Sun; Nicole Gui Zhen Tee; Elisabeth Li Sa Tan; Paul J R Barton; Leanne E Felkin; Enrique Lara-Pezzi; Gianni Angelini; Cristina Beltrami; Michal Pravenec; Sebastian Schafer; Leonardo Bottolo; Norbert Hubner; Costanza Emanueli; Stuart A Cook; Enrico Petretto
Journal:  Nat Commun       Date:  2019-08-09       Impact factor: 14.919

Review 6.  The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy.

Authors:  Richard C Becker; A Phillip Owens; Sakthivel Sadayappan
Journal:  Thromb Res       Date:  2020-05-07       Impact factor: 3.944

7.  Systems Genetics Approaches in Rat Identify Novel Genes and Gene Networks Associated With Cardiac Conduction.

Authors:  Michiel E Adriaens; Elisabeth M Lodder; Aida Moreno-Moral; Jan Šilhavý; Matthias Heinig; Charlotte Glinge; Charly Belterman; Rianne Wolswinkel; Enrico Petretto; Michal Pravenec; Carol Ann Remme; Connie R Bezzina
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.